相关实验视频

Updated: Jul 17, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

A+T丰富的相互作用域蛋白3a (Arid3a) 损害了Mertk介导的胆固醇中胆固醇细胞分裂

Ruiling Chen¹, Bingyuan Huang¹, Min Lian¹

¹Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai Jiao Tong University; Shanghai Institute of Digestive Disease; 145 Middle Shandong Road, Shanghai 200001, China.

Journal of hepatology

|September 2, 2023

概括

阿里德3a通过阻碍巨细胞对质胆固醇细胞的默特克介导的效细胞化来促进胆固醇性肝损伤. 准Arid3a-Mertk通路为胆固醇性肝病提供了一个潜在的治疗策略.

科学领域:

肝病学肝病学是一种肝病学.
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

巨细胞在胆固醇性肝病的发病过程中至关重要.
Arid3a在胆固醇中对巨细胞功能的作用以前是未知的.

研究的目的:

研究Arid3a在巨细胞功能和胆固醇性肝损伤中的作用.
阐明Arid3a影响胆固醇形成的分子机制.

主要方法:

产生的骨髓特异性Arid3a淘汰赛小鼠和胆固醇模型.
通过qPCR,IHC,IF,流细胞计和RNA-seq.评估基因/蛋白质表达,细胞定位和转录组.
使用了Mertk抑制剂和促进剂活性试验 (ChIP-seq, luciferase).

主要成果:

删除Arid3a减轻了肝损伤和减少了巨细胞的积累.
缺乏Arid3a的巨细胞通过Mertk上调表现出通过Mertk上调来增强apoptotic cholangiocytes的效细胞增强.
Arid3a直接抑制了梅特克转录;针对梅特克逆转了保护作用.
在人类胆固醇性肝病 (PBC,PSC) 中,Arid3a和Mertk水平发生变化.

结论:

Arid3a通过损害Mertk介导的肝细胞分裂促进胆固醇性肝损伤.
Arid3a-Mertk轴代表了胆固醇性肝病的新型治疗标.

关键词:

这就是ARID3A.这就是MERTK的意思.胆固醇的形成.这种细胞的形成是Efferocytosis.巨细胞是什么?巨细胞是什么?

更多相关视频

Ileectomy-induced Bile Overaccumulation in Mouse Intestine

Ileectomy-induced Bile Overaccumulation in Mouse Intestine

Published on: August 21, 2017

Quantification of Efferocytosis by Single-cell Fluorescence Microscopy

Quantification of Efferocytosis by Single-cell Fluorescence Microscopy

Published on: August 18, 2018

相关概念视频

Export of Misfolded Proteins out of the ER

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...